VECTUS BIOSYSTEMS LIMITED (VBS)
AI Coverage Rating: Low
ASX AI Signals has generated 0 signals for VBS during the last 90 days, indicating low trading activity
VBS Share Price | |
| Current Price | $0.115 |
| 52 Week High | $0.440 |
| 52 Week Low: | $0.037 |
| Trading at (% of 52 Week High) | 26.14% |
Business Overview
Vectus Biosystems Limited (ASX: VBS) is a biotechnology company focused on developing and commercializing medical devices and technologies. The company specializes in innovative solutions for the treatment of cardiovascular and other diseases, aiming to improve patient outcomes.
ASX Sector Overview
Sector: Pharmaceuticals, Biotechnology & Life Sciences
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
Latest AI Recommendation
Latest VECTUS BIOSYSTEMS LIMITED(VBS) News
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial